Profiling pancreatic cancer-secreted proteome using 15N amino acids and serum-free media

Pancreas

Volumn 39, Issue 1, 2010, Pages

  Xiao, Jing ^a,b   Lee, Wai Nang Paul ^c   Zhao, Yingchun ^a   Cao, Rui ^a   Go, Vay Liang W ^c   Recker, Robert R ^a   Wang, Qi ^d   Xiao, Gary Guishan ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUNAN NORMAL UNIVERSITY   (China)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

15N stable isotope; Oxythiamine; Pancreatic cancer; Quantitative proteomics; Secreted proteome

Indexed keywords

AMINO ACID; AMINO ACID MIXTURE; BOVINE SERUM ALBUMIN; CYTOKERATIN; CYTOKERATIN 10; NITROGEN 15; OXYTHIAMINE; PROTEOME; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ALGAL CELL CULTURE; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; METABOLIC RATE; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTIMETABOLITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KERATIN-10; MASS SPECTROMETRY; OXYTHIAMINE; PANCREAS; PANCREATIC NEOPLASMS; PROTEOME; PROTEOMICS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 74049102336     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bc44dd     Document Type: Article

References (27)

1. Bonin-Debs AL, Boche I, Gille H, et al. Development of secreted proteins as biotherapeutic agents. Expert Opin Biol Ther. 2004; 4:551-558.
2. Kulasingam V, Diamandis EP. Tissue culture based breast cancer biomarker discovery platform. Int J Cancer. 2008;123:2007-2012.
3. Zhao Y, Lee WN, Xiao GG, et al. Quantitative proteomics: measuring protein synthesis using 15N amino acid labeling in pancreatic cancer cells. Anal Chem. 2009;81:764-771.
4. Flora JW, Edmiston J, McKinney W, et al. Identification of in vitro differential cell secretions due to cigarette smoke condensate exposure using nanoflow capillary liquid chromatography and highresolution mass spectrometry. Anal Bioanal Chem. 2008;391:2845-2856.
5. Haqqani AS, Kelly J, Stanimirovic DB, et al. Protein markers of ischemic insult in brain endothelial cells identified using 2D gel electrophoresis and ICAT-based quantitative proteomics. J Proteome Res. 2007;6:226-239.
6. Sambrook J, Russell D. Molecular cloning: a laboratory manual. ed 3, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001.
7. Senechal KR, Thaller C, Noebels JL. ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum Mol Genet. 2005;14:1613-1620.
8. Toussaint-Smith E, Donner DB, Roman A. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene. 2004;23:2988-2995.
9. Moore MK, Viselli SM. Staining and quantification of proteins transferred to polyvinylidene fluoride membranes. Anal Biochem. 2000;279:241-242.
10. Rockenstein E, Mante M, Masliah E, et al. High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels: implications for the treatment of Alzheimer disease. J Biol Chem. 2005;280:32957-32967.
11. Sundaram R, Lynch MP, Kaumaya PT, et al. De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies. J Biol Chem. 2004;279:24141-24151.
12. Hui EP, Sung FL, Chan AT, et al. Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer. Clin Cancer Res. 2008;14:7080-7087.
13. Xiao GG, Garg M, Lee WN, et al. Determination of protein synthesis in vivo using labeling from deuterated water and analysis of MALDITOF spectrum. J Appl Physiol. 2008;104:828-836.
14. Boros LG, Puigjaner J, Schirmer WJ, et al. Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res. 1997;57:4242-4248.
15. Rais B, Comin B, Cascante M, et al. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett. 1999;456:113-118.
16. Cottam DW, Rees RC. Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis. Int J Oncol. 1993;2: 861-872.
17. Sato H, Takino T, Seiki M, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994;370:61-65.
18. Stetler-Stevenson WG. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal. 2008;1:re6.
19. Singla DK, McDonald DE. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol Heart Circ Physiol. 2007;293:H1590-1595.
20. Gomis-Ruth FX, Maskos K, Bode W. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature. 1997;389:77-81.
21. Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33:266-270.
22. Kageyama S, Isono T, Yoshiki T, et al. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin Chem. 2004;50:857-866.
23. Ong SE, Blagoev B, Mann M, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1:376-386.
24. Gruhler S, Kratchmarova I. Stable isotope labeling by amino acids in cell culture (SILAC). Methods Mol Biol. 2008;424:101-111.
25. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 1991;51: 5054s-5059s.
26. Bramhall SR, Neoptolemos JP, Lemoine NR, et al. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol. 1997;182:347-355.
27. Gong YL, Xu GM, Chen LB, et al. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer. J Surg Oncol. 2000;73:95-99.